American Society of Hematology (ASH) Oral Presentation: Viralym-C

Safety and Preliminary Efficacy of “Ready to Administer” Cytomegalovirus (CMV)-Specific T cells for the Treatment of Patients with Refractory CMV Infection (Abstract 388. ASH 2016 Annual Meeting)